Scintimun European Union - English - EMA (European Medicines Agency)

scintimun

cis bio international  - besilesomab - osteomyelitis; radionuclide imaging - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only and the approved indication is scintigraphic imaging, in conjunction with other appropriate imaging modalities, for determining the location of inflammation/infection in peripheral bone in adults with suspected osteomyelitis. scintimun should not be used for the diagnosis of diabetic foot infection.